Clinical Trial Update: Phase II SBRT & Chemo for Unresectable Cholangiocarcinoma Followed by Liver Transplantation [Phase 2]

View source ↗

Summary

Phase II trial of SBRT and chemotherapy for unresectable cholangiocarcinoma followed by liver transplantation was terminated; results were posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholangiocarcinoma
• Gallbladder Cancer
• Hepatocellular Carcinoma

Snippet

Sponsor: Stanford University | Conditions: Cholangiocarcinoma, Hepatobiliary Neoplasm | Phase 2 | Status: TERMINATED | Results posted: 2016-05-26